Heme Oxygenase 1 Impairs Glucocorticoid Receptor Activity in Prostate Cancer

Glucocorticoids are used during prostate cancer (PCa) treatment. However, they may also have the potential to drive castration resistant prostate cancer (CRPC) growth via the glucocorticoid receptor (GR). Given the association between inflammation and PCa, and the anti-inflammatory role of heme oxyg...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonardi, Daiana B., Anselmino, Nicolás, Brandani, Javier N., Jaworski, Felipe M., Páez, Alejandra V., Mazaira, Gisela, Meiss, Roberto P., Nuñez, Myriam, Nemirovsky, Sergio I., Giudice, Jimena, Galigniana, Mario, Pecci, Adalí, Gueron, Geraldine, Vazquez, Elba, Cotignola, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429053/
https://www.ncbi.nlm.nih.gov/pubmed/30813528
http://dx.doi.org/10.3390/ijms20051006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429053/
https://www.ncbi.nlm.nih.gov/pubmed/30813528
http://dx.doi.org/10.3390/ijms20051006

Ejemplares similares